SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT



                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                       DATE OF REPORT -- DECEMBER 9, 2003
                        (Date of earliest event reported)



                        ALKERMES CLINICAL PARTNERS, L.P.
             (Exact name of Registrant as specified in its charter)



       DELAWARE                     0-26758                    043-145043
(State of organization)      (Commission file number)         (IRS employer
                                                          identification number)





                88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS 02139
               (Address of principal executive offices, zip code)


                            AREA CODE (617) 494-0171
                               (Telephone number)






ITEM 5.  OTHER EVENTS.
         ------------

The Limited Partners of Alkermes Clinical Partners, L.P. met on December 9, 2003
and voted to adjourn the scheduled Special Meeting of Limited Partners until
10:00 a.m., local time, on December 17, 2003. The Special Meeting will reconvene
at the offices of Alkermes, Inc., 88 Sidney Street, Cambridge, Massachusetts
02139 for the following purposes:

          1.   To consider and vote upon a proposal to terminate Alkermes
               Clinical Partners, L.P. pursuant to Section 9.1 of the Alkermes
               Clinical Partners, L.P. Agreement of Limited Partnership, dated
               February 7, 1992, as amended, among Alkermes Development
               Corporation, II, a Delaware corporation, the Initial Limited
               Partner and Additional Limited Partners.

          2.   To transact such other business as may properly come before the
               meeting.

     Only holders of record of Alkermes Clinical Partners, L.P. limited
partnership interests at the close of business on October 2, 2003 are entitled
to vote at the adjourned special meeting or any subsequent adjournments or
postponements thereof. Approval of the termination proposal at the special
meeting requires the favorable vote of the holders of at least two-thirds in
interest of the Limited Partners in person or by proxy.










                                   SIGNATURES
                                   ----------



     Pursuant to requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.




Dated: December 15, 2003            Alkermes Clinical Partners, L.P.



                                    By: /s/ James M. Frates
                                        ----------------------------------------
                                        James M. Frates
                                        Chief Financial Officer, Vice President,
                                        Treasurer and Assistant Secretary